 CALIFORNIA
Los
Angeles
University of California
Division of Rheumatology
1000 Veteran Avenue
Rehab Center Room 32-59
Box 951670
Los Angeles, CA 90095-1670
Telephone: 310-825-8414 and 310-825-4744
Fax:310-206-8606
Contacts:
Dinesh Khanna, M.D., M.S. at dkhanna@mednet.UCLA.edu
Sarah Delgado at sedelgado@mednet.ucla.edu
| Studies |
Status |
Scleroderma Lung Study 2
http://sls.med.ucla.edu/nav6.html |
Open |
| Ambrisentan in Patients with Scleroderma |
Open |
CRISS: Provisional Combined Response Index For Patients With Diffuse Systemic Sclerosis |
Open |
DETECT: A Study to Determine The Best Methods to Determine if Patients Have Pulmonary Arterial Hypertension in Patients With Scleroderma |
Open |
DISTOL: a study using Treprostinil Diethanolamine (UT-15C) or Placebo Subjects With Scleroderma |
Open |
Imatinib (Gleevac) in Subjects with Systemic Sclerosis |
Closed |
Quality of Life |
Open |
SCOT study (Scleroderma Cyclophosphamide
Or Transplantation)
www.clinicaltrials.gov/ct/gui/show/NCT00114530 |
Open |
The Natural History and Outcome of Patients with Scleroderma at High Risk for or with Early Pulmonary Hypertension (PHAROS) |
Open |
|
Trials that will be opening soon at UCLA are:
- Dasatinib for Subjects With Scleroderma
- MEDI-546 in Subjects With Scleroderma
|
Physician Affiliated with this Center:
Dinesh Khanna, M.D., M.S.
Philip Clements, M.D., M.P.H.
Daniel Furst, M.D. |
